No Prescription |
 |
 | ||
|
Flagyl Flagyl ER |
|
| ||
No Prescription » Prescription Drugs 7 » Flagyl Flagyl ER Category:Anthelmintic systemic Antibacterial systemic Antiprotozoal Bowel disease inflammatory suppressant Flagyl is used for: Treating certain infections caused by bacteria or amoebas. Metronidazole is an antibiotic. It fights bacteria in your body.Metronidazole is used to treat bacterial infections of the vagina stomach skin joints and respiratory tract. This medication will not treat a vaginal yeast infection.Flagyl is an antibacterial drug prescribed for certain vaginal and urinary tract infections in men and women; amebic dysentery and liver abscess; and infections of the abdomen skin bones and joints brain lungs and heart caused by certain bacteria.Metronidazole (me-troe-NI-da-zole) is used to treat infections. It may also be used for other problems as determined by your doctor. It will not work for colds flu or other virus infections. Buy Flagyl Flagyl ER and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Flagyl Flagyl ER: Product Type: Prescription Drugs 7 Flagyl ( Flagyl ER Generic Metronidazole ) Flagyl (Flagyl ER Generic Metronidazole) Flagyl ER Generic Metronidazole 200mg 400mg 100(10 x 10 Tablets) 200(20 x 10 Tablets) 90(6 x 15 Tablets) 180(12 x 15 Tablets) Flagyl ER Generic Metronidazole Flagyl
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
